The Special Situation Report

The Special Situation Report

Share this post

The Special Situation Report
The Special Situation Report
Merck Expands Oncology Pipeline With SpringWorks Deal – Merger Arbitrage Mondays
Copy link
Facebook
Email
Notes
More

Merck Expands Oncology Pipeline With SpringWorks Deal – Merger Arbitrage Mondays

Asif's avatar
Asif
May 05, 2025
∙ Paid

Share this post

The Special Situation Report
The Special Situation Report
Merck Expands Oncology Pipeline With SpringWorks Deal – Merger Arbitrage Mondays
Copy link
Facebook
Email
Notes
More
Share

SpringWorks Therapeutics, Inc. (SWTX): $46.23

Market Cap: $3.47 B

Deal Value: $3.4 B

Germany’s Merck KGaA entered a merger agreement on April 28, 2025, to acquire U.S.-based SpringWorks Therapeutics in an all-cash deal valued at $3.4 billion.

Under the terms of the agreement, Merck KGaA will acquire SpringWorks for $47 per share in cash, representing a prem…

Keep reading with a 7-day free trial

Subscribe to The Special Situation Report to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 The Special Situation Report
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More